To date, patients with a clinical suspicion of prostate cancer (PCa) based on elevated serum prostate specific antigen (PSA) and/or a suspicious digital rectal examination (DRE) should undergo a transrectal ultrasound (TRUS)-guided systematic biopsy as next step in assessing presence of PCa [1]. Here, KLK3 is linked to prostate carcinoma.